2016
DOI: 10.4155/bio-2016-0062
|View full text |Cite
|
Sign up to set email alerts
|

Discovery Bioanalysis and In Vivo Pharmacology as an Integrated Process: A Case Study in Oncology Drug Discovery

Abstract: This process provided unique opportunities for the characterization of drug properties, selection and assessment of compounds in animal models and to support and expedite proof-of-concept studies in oncology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…Interest in using high-resolution MS (HRMS) continues to expand in the bioanalysis arena as well as other pharmaceutical applications [2][3][4][5][6][7][8][9]. In addition to DMPK applications based on small molecules [10][11][12], HRMS is also being utilized for large molecules including proteins and peptide therapeutics [13][14][15].…”
mentioning
confidence: 99%
“…Interest in using high-resolution MS (HRMS) continues to expand in the bioanalysis arena as well as other pharmaceutical applications [2][3][4][5][6][7][8][9]. In addition to DMPK applications based on small molecules [10][11][12], HRMS is also being utilized for large molecules including proteins and peptide therapeutics [13][14][15].…”
mentioning
confidence: 99%